OZ Biosciences Overview
- Year Founded
-
2003
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
OZ Biosciences General Information
Description
Developer of molecular delivery systems designed for transfection and transduction. The company product line includes magnetoreception which uses magnetic drug targeting technology, lipofection lipid-based transfection technology, genome editing transfection reagents, transduction tools, 3D transfection reagents, protein delivery systems, and vaccine adjuvants, enabling customers with goal-oriented transfection service.
Contact Information
Website
www.ozbiosciences.comCorporate Office
- 163 Avenue de Luminy, Zone Entreprise, Case 922
- Cedex 09
- 13288 Marseille
- France
Corporate Office
- 163 Avenue de Luminy, Zone Entreprise, Case 922
- Cedex 09
- 13288 Marseille
- France
OZ Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Secondary Transaction - Private | 18-May-2016 | Completed | Generating Revenue | |||
2. Seed Round | 01-Sep-2009 | Completed | Generating Revenue | |||
1. Accelerator/Incubator | Completed | Startup |
OZ Biosciences Comparisons
Industry
Financing
Details
OZ Biosciences Competitors (8)
One of OZ Biosciences’s 8 competitors is Promega, a Formerly PE-Backed company based in Madison, WI.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Promega | Formerly PE-Backed | Madison, WI | ||||
Polyplus (Biotechnology) | Formerly PE-Backed | Illkirch-Graffenstaden, France | ||||
Mirus Bio | Formerly PE-Backed | Madison, WI | ||||
Genlantis | Corporation | San Diego, CA | ||||
Takara Bio | Corporation | Kusatsu, Japan |
OZ Biosciences Patents
OZ Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220267803-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | ||
EP-3999649-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | ||
AU-2020314617-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | ||
CA-3140460-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | ||
EP-3766981-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | C12N15/87 |
OZ Biosciences Signals
OZ Biosciences Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Grand Luminy | Corporation | Minority | ||
Incubateur Impulse | Accelerator/Incubator | Minority |
OZ Biosciences FAQs
-
When was OZ Biosciences founded?
OZ Biosciences was founded in 2003.
-
Where is OZ Biosciences headquartered?
OZ Biosciences is headquartered in Marseille, France.
-
What is the size of OZ Biosciences?
OZ Biosciences has 20 total employees.
-
What industry is OZ Biosciences in?
OZ Biosciences’s primary industry is Biotechnology.
-
Is OZ Biosciences a private or public company?
OZ Biosciences is a Private company.
-
What is OZ Biosciences’s current revenue?
The current revenue for OZ Biosciences is
. -
Who are OZ Biosciences’s investors?
Grand Luminy and Incubateur Impulse have invested in OZ Biosciences.
-
Who are OZ Biosciences’s competitors?
Promega, Polyplus (Biotechnology), Mirus Bio, Genlantis, and Takara Bio are some of the 8 competitors of OZ Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »